Furosemide Injection Clinical Trials

3 actively recruiting trials

Also known as: 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

University of Alberta1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Johannes Grand1

Indications

Heart Disease2
Cardio-Renal Syndrome1
Acute Heart Failure1
Congestive Heart Failure1
Pulmonary Edema1

Other3 trials

18F-DOPA II - PET Imaging Optimization

Phase 3

Kidney Sodium Content in Cardiorenal Patients

N/A

Optimized Treatment of Pulmonary Edema or Congestion

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.